Aroa Biosurgery Ltd (AU:ARX) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Aroa Biosurgery Ltd reported a 25% increase in product sales revenue for the six months ending September 2024, reaching NZ$39.1 million, despite a significant drop in project fees. The company’s loss before tax improved, decreasing by 53% compared to the previous year, highlighting a positive trend in financial performance. However, net tangible assets per security saw a slight decline, closing at NZ$0.19.
For further insights into AU:ARX stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue